Prostate Cancer
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol.
September 26, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
September 25, 2023
Development and evaluation of the MiCheckĀ® Prostate test for clinically significant prostate cancer.
September 25, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
September 25, 2023
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
September 25, 2023
Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer.
September 25, 2023
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
September 25, 2023
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers.
September 25, 2023
Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men.
September 25, 2023
Exploring the Association Between Online Health Information and Racial Disparities in Prostate Cancer.
September 25, 2023
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
September 25, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.
September 25, 2023
Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities.
September 25, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
September 25, 2023
Fifteen-Year Outcomes of the ProtecT Trial for Localized Prostate Cancer.
September 25, 2023